IL9 and cancer: To study the contribution of mast cells to the anti-cancer effects triggered by IL-9 administration in vivo, the authors treated LLC1 and B16 tumor-bearing kit W-sh mice with IL-9 and found that the anti-tumor effects of IL-9 relied on mast cells in both tumor models [22, 25].